Regulation of transporters by nuclear hormone receptors: Implications during inflammation

Molecular Pharmaceutics

Volumn 5, Issue 1, 2008, Pages 67-76

  Teng, Shirley ^a   Piquette Miller, Micheline ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cytokines; Drug transporters; Inflammation; Nuclear receptors; PXR

Indexed keywords

16ALPHA CYANOPREGNENOLONE; ATORVASTATIN; BREAST CANCER RESISTANCE PROTEIN; CHOLIC ACID; CISPLATIN; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOKINE; DIGOXIN; DISCODERMOLIDE; FARNESOID X RECEPTOR; FEXOFENADINE; GLYCOPROTEIN P; HYPERFORIN; LIPOPOLYSACCHARIDE; MIFEPRISTONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; N (2 FLUORENYL)ACETAMIDE; ORGANIC ANION TRANSPORTER 1; PACLITAXEL; PHENOBARBITAL; PRAVASTATIN; PREGNANE X RECEPTOR; RIFAMPICIN; RITONAVIR; SAQUINAVIR; TAMOXIFEN; XENOBIOTIC AGENT;

BREAST CANCER; CANCER CELL; CHOLESTASIS; DRUG DISPOSITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG TRANSPORT; ENTERITIS; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; INFLAMMATION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; BIOLOGICAL TRANSPORT; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MEMBRANE TRANSPORT PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 39749190047     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp700102q     Document Type: Review

References (103)

1. Hartmann, G.; Vassileva, V.; Piquette-Miller, M. Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. Drug Metab. Dispos. 2005, 33 (6), 820-8.
2. Goralski, K. B.; Hartmann, G.; Piquette-Miller, M.; Renton, K. W. Downregulation of mdrla expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br. J. Pharmacol. 2003, 139 (1), 35-48.
3. Naud, J.; Michaud, J.; Boisvert, C.; Desbiens, K.; Leblond, F. A.; Mitchell, A.; Jones, C.; Bonnardeaux, A.; Pichette, V. Downregulation of intestinal drug transporters in chronic renal failure in rats. J. Pharmacol. Exp. Ther. 2007, 320 (3), 978-85.
4. Fradette, C.; Batonga, J.; Teng, S.; Piquette-Miller, M.; du Souich, P. Animal models of acute moderate hypoxia are associated with a down-regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and up-regulation of CYP3A6 and P-glycoprotein in liver. Drug Metab. Dispos. 2007, 35 (5), 765-71.
5. Charles, K. A.; Rivory, L. P.; Brown, S. L.; Liddle, C.; Clarke, S. J.; Robertson, G. R. Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer. Clin. Cancer Res. 2006, 12 (24), 7492-7.
6. Kartenbeck, J.; Leuschner, U.; Mayer, R.; Keppler, D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996, 23 (5), 1061-6.
7. Strautnieks, S. S.; Bull, L. N.; Knisely, A. S.; Kocoshis, S. A.; Dahl, N.; Arnell, H.; Sokal, E.; Dahan, K.; Childs, S.; Ling, V.; Tanner, M. S.; Kagalwalla, A. F.; Nemeth, A.; Pawlowska, J.; Baker, A.; Mieli-Vergani, G.; Freimer, N. B.; Gardiner, R. M.; Thompson, R. J. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 1998, 20 (3), 233-8.
8. Schneider, R. E.; Bishop, H.; Kendall, M. J.; Quarterman, C. P. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents. Int. J. Clin. Pharmacol. Ther. Toxicol. 1981, 19 (4), 158-62.
9. Piquette-Miller, M.; Jamali, F. Effect of adjuvant arthritis on me disposition of acebutolol enantiomers in rats. Agents Actions 1992, 37 (3-4), 290-6.
10. Piquette-Miller, M.; Jamali, F. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay. Pharm. Res. 1993, 10 (2), 294-9.
11. Petrovic, V.; Teng, S.; Piquette-Miller, M. Regulation of drug transporters during infection and inflammation. Mol. Interv. 2007, 7 (2), 99-111.
12. Lee, G.; Piquette-Miller, M. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can. J. Physiol. Pharmacol. 2001, 79 (10), 876-84.
13. Sukhai, M.; Yong, A.; Kalitsky, J.; Piquette-Miller, M. Inflammation and interleukin-6 mediate reductions in the hepatic expression and transcription of the mdr1a and mdr1b Genes. Mol. Cell Biol. Res. Commun. 2000, 4 (4), 248-56.
14. Chen, Y. L.; Le Vraux, V.; Leneveu, A.; Dreyfus, F.; Stheneur, A.; Florentin, I.; De Sousa, M.; Giroud, J. P.; Flouvat, B.; Chauvelot-Moachon, L. Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin. Pharmacol. Ther. 1994, 55 (6), 649-60.
15. Pheterson, A. D.; Miller, L.; Fox, C. F.; Estroff, T. W.; Sweeney, D. R. Multifocal neurological impairment caused by infection-induced rise in blood lithium and amitriptyline. Int. J. Psychiatry Med. 1986, 16 (3), 257-62.
16. Deeley, R. G.; Westlake, C.; Cole, S. P. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 2006, 86 (3), 849-99.
17. Hagenbuch, B.; Meier, P. J. The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta 2003, 1609 (1), 1-18.
18. Owen, A.; Chandler, B.; Back, D. J.; Khoo, S. H. Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA. Antivir. Ther. 2004, 9 (5), 819-21.
19. Albermann, N.; Schmitz-Winnenthal, F. H.; Z'Graggen, K.; Volk, C.; Hoffmann, M. M.; Haefeli, W. E.; Weiss, J. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem. Pharmacol. 2005, 70 (6), 949-58.
20. Geick, A.; Eichelbaum, M.; Burk, O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 2001, 276 (18), 14581-7.
21. Synold, T. W.; Dussault, I.; Forman, B. M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 2001, 7 (5), 584-90.
22. Teng, S.; Piquette-Miller, M. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J. Pharmacol. Exp. Ther. 2005, 312 (2), 841-8.
23. Matheny, C. J.; Ali, R. Y.; Yang, X.; Pollack, G. M. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues. Drug Metab. Dispos. 2004, 32 (9), 1008-14.
24. Burk, O.; Arnold, K. A.; Geick, A.; Tegude, H.; Eichelbaum, M. A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol. Chem. 2005, 386 (6), 503-13.
25. Smit, J. J.; Schinkel, A. H.; Oude Elferink, R. P.; Groen, A. K.; Wagenaar, E.; van Deemter, L.; Mol, C. A.; Ottenhoff, R.; van der Lugt, N. M.; van Roon, M.A. et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993, 75 (3), 451-62.
26. Kok, T.; Bloks, V. W.; Wolters, H.; Havinga, R.; Jansen, P. L.; Staels, B.; Kuipers, F. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem. J. 2003, 369 (Pt 3), 539-47.
27. Ananthanarayanan, M.; Balasubramanian, N.; Makishima, M.; Mangelsdorf, D. J.; Suchy, F. J. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. 2001, 276 (31), 28857-65.
28. Plass, J. R.; Mol, O.; Heegsma, J.; Geuken, M.; Faber, K. N.; Jansen, P. L.; Muller, M. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology 2002, 35 (3), 589-96.
29. Sinal, C. J.; Tohkin, M.; Miyata, M.; Ward, J. M.; Lambert, G.; Gonzalez, F. J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102 (6), 731-44.
30. Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258 (5088), 1650-4.
31. Kauffmann, H. M.; Pfannschmidt, S.; Zoller, H.; Benz, A.; Vorderstemann, B.; Webster, J. I.; Schrenk, D. Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression. Toxicology 2002, 171 (2-3), 137-46.
32. Kast, H. R.; Goodwin, B.; Tarr, P. T.; Jones, S. A.; Anisfeld, A. M.; Stoltz, C. M.; Tontonoz, P.; Kliewer, S.; Willson, T. M.; Edwards, P. A. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem. 2002, 277 (4), 2908-15.
33. Anapolsky, A.; Teng, S.; Dixit, S.; Piquette-Miller, M. The role of pregnane x receptor in 2-acetylaminofluorene-mediated induction of drug transport and -metabolizing enzymes in mice. Drug Metab. Dispos. 2006, 34 (3), 405-9.
34. Teng, S.; Piquette-Miller, M. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br. J. Pharmacol. 2007, 151 (3), 367-76.
35. Cheng, X.; Klaassen, C. D. Regulation of mRNA expression of xenobiotic transporters by the pregnane x receptor in mouse liver, kidney, and intestine. Drug Metab. Dispos. 2006, 34 (11), 1863-7.
36. Jigorel, E.; Le Vee, M.; Boursier-Neyret, C.; Parmentier, Y.; Fardel, O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab. Dispos. 2006, 34 (10), 1756-63.
37. Teng, S.; Jekerle, V.; Piquette-Miller, M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab. Dispos. 2003, 31 (11), 1296-9.
38. Staudinger, J. L.; Madan, A.; Carol, K. M.; Parkinson, A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. 2003, 31 (5), 523-7.
39. Moffit, J. S.; Aleksunes, L. M.; Maher, J. M.; Scheffer, G. L.; Klaassen, C. D.; Manautou, J. Induction of hepatic transporters Mrp3 and Mrp4 by clofibrate is regulated by PPAR{alpha}. J. Pharmacol. Exp. Ther. 2006.
40. McCarthy, T. C.; Li, X.; Sinai, C. J. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J. Biol. Chem. 2005, 280 (24), 23232-42.
41. Slitt, A. L.; Cherrington, N. J.; Dieter, M. Z.; Huang, W.; Aleksunes, L. M.; Scheffer, G. L.; Moore, D. D.; Klaassen, C. D. Trans-stilbene oxide induces expression of genes involved in metabolism and disposition in mouse liver via CAR and Nrf2 transcription factors. Mol. Pharmacol. 2006.
42. Cherrington, N. J.; Slitt, A. L.; Maher, J. M.; Zhang, X. X.; Zhang, J.; Huang, W.; Wan, Y. J.; Moore, D. D.; Klaassen, C. D. Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab. Dispos. 2003, 31 (11), 1315-9.
43. Cherrington, N. J.; Hartley, D. P.; Li, N.; Johnson, D. R.; Klaassen, C. D. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther. 2002, 300 (1), 97-104.
44. Rausch-Derra, L. C.; Hartley, D. P.; Meier, P. J.; Klaassen, C. D. Differential effects of microsomal enzyme-inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2. Hepatology 2001, 33 (6), 1469-78.
45. Wagner, M.; Halilbasic, E.; Marschall, H. U.; Zollner, G.; Fickert, P.; Langner, C.; Zatloukal, K.; Denk, H.; Trauner, M. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 2005, 42 (2), 420-30.
46. Frank, C.; Makkonen, H.; Dunlop, T. W.; Matilainen, M.; Vaisanen, S.; Carlberg, C. Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. J. Mol. Biol. 2005, 346 (2), 505-19.
47. Guo, G. L.; Staudinger, J.; Ogura, K.; Klaassen, C. D. Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor. Mol. Pharmacol. 2002, 61 (4), 832-9.
48. Hagenbuch, N.; Reichel, C.; Stieger, B.; Cattori, V.; Fattinger, K. E.; Landmann, L.; Meier, P. J.; Kullak-Ublick, G. A. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J. Hepatol. 2001, 34 (6), 881-7.
49. Rost, D.; Herrmann, T.; Sauer, P.; Schmidts, H. L.; Stieger, B.; Meier, P. J.; Stremmel, W.; Stiehl, A. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. Hepatology 2003, 38 (1), 187-95.
50. Denson, L. A.; Sturm, E.; Echevarria, W.; Zimmerman, T. L.; Makishima, M.; Mangelsdorf, D. J.; Karpen, S. J. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 2001, 121 (1), 140-7.
51. Zollner, G.; Wagner, M.; Fickert, P.; Geier, A.; Fuchsbichler, A.; Silbert, D.; Gumhold, J.; Zatloukal, K.; Kaser, A.; Tilg, H.; Denk, H.; Trauner, M. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289 (5), G798-805.
52. Richardson, T. A.; Morgan, E. T. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J. Pharmacol. Exp. Ther. 2005, 314 (2), 703-9.
53. Beigneux, A. P.; Moser, A. H.; Shigenaga, J. K.; Grunfeld, C.; Feingold, K. R. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun. 2002, 293 (1), 145-9.
54. Pascussi, J. M.; Gerbal-Chaloin, S.; Pichard-Garcia, L.; Daujat, M.; Fabre, J. M.; Maurel, P.; Vilarem, M. J. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem. Biophys. Res. Commun. 2000, 274 (3), 707-13.
55. Fang, C.; Yoon, S.; Tindberg, N.; Jarvelainen, H. A.; Lindros, K. O.; Ingelman-Sundberg, M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem. Pharmacol. 2004, 67 (7), 1389-97.
56. Sachdeva, K.; Yan, B.; Chichester, C. O. Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A. Shock 2003, 19 (5), 469-74.
57. Tirona, R. G.; Lee, W.; Leake, B. F.; Lan, L. B.; Cline, C. B.; Lamba, V.; Parviz, F.; Duncan, S. A.; Inoue, Y.; Gonzalez, F. J.; Schuetz, E. G.; Kim, R. B. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med. 2003, 9 (2), 220-4.
58. Kamiya, A.; Inoue, Y.; Gonzalez, F. J. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology 2003, 37 (6), 1375-84.
59. Li, J.; Ning, G.; Duncan, S. A. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 2000, 14 (4), 464-74.
60. Geier, A.; Zollner, G.; Dietrich, C. G.; Wagner, M.; Fickert, P.; Denk, H.; van Rooijen, N.; Matern, S.; Gartung, C.; Trauner, M. Cytokine-independent repression of rodent Ntcp in obstructive cholestasis. Hepatology 2005, 41 (3), 470-7.
61. Gibson, G. G.; Phillips, A.; Aouabdi, S.; Plant, K.; Plant, N. Transcriptional regulation of the human pregnane-X receptor. Drug Metab. Rev. 2006, 38 (1-2), 31-49.
62. Pascussi, J. M.; Drocourt, L.; Fabre, J. M.; Maurel, P.; Vilarem, M. J. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol. Pharmacol. 2000, 58 (2), 361-72.
63. Aouabdi, S.; Gibson, G.; Plant, N. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR. Drug Metab. Dispos. 2006, 34 (1), 138-44.
64. Jung, D.; Mangelsdorf, D. J.; Meyer, U. A. Pregnane X receptor is a target of farnesoid X receptor. J. Biol. Chem. 2006, 281 (28), 19081-91.
65. Beigneux, A. P.; Moser, A. H.; Shigenaga, J. K.; Grunfeld, C.; Feingold, K. R. The acute phase response is associated with retinoid X receptor repression in rodent liver. J. Biol. Chem. 2000, 275 (21), 16390-9.
66. Kim, M. S.; Shigenaga, J.; Moser, A.; Feingold, K.; Grunfeld, C. Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 2003, 278 (11), 8988-95.
67. Gu, X.; Ke, S.; Liu, D.; Sheng, T.; Thomas, P. E.; Rabson, A. B.; Gallo, M. A.; Xie, W.; Tian, Y. Role of NF-kappa B in regulation of PXR-mediated gene expression: A mechanism for the suppression of cytochrome P450 3A4 by proinflammatory agents. J. Biol. Chem. 2006.
68. Zhou, C.; Tabb, M. M.; Nelson, E. L.; Grun, F.; Verma, S.; Sadatrafiei, A.; Lin, M.; Mallick, S.; Forman, B. M.; Thummel, K. E.; Blumberg, B. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J. Clin. Invest. 2006, 116 (8), 2280-2289.
69. Xu, D. X.; Wei, W.; Sun, M. F.; Wu, C. Y.; Wang, J. P.; Wei, L. Z.; Zhou, C. F. Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane x receptor and its target gene CYP3a in mouse liver. Free Radic. Biol. Med. 2004, 37 (1), 10-22.
70. Xu, D. X.; Wei, W.; Sun, M. F.; Wei, L. Z.; Wang, J. P. Melatonin attenuates lipopolysaccharide-induced down-regulation of pregnane X receptor and its target gene CYP3A in mouse liver. J. Pineal Res. 2005, 38 (1), 27-34.
71. Ardizzone, S.; Maconi, G.; Bianchi, V.; Russo, A.; Colombo, E.; Cassinotti, A.; Penati, C.; Tenchini, M. L.; Bianchi Porro, G. Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm. Bowel Dis. 2007, 13 (5), 516-23.
72. Schwab, M.; Schaeffeler, E.; Marx, C.; Fromm, M. F.; Kaskas, B.; Metzler, J.; Stange, E.; Herfarth, H.; Schoelmerich, J.; Gregor, M.; Walker, S.; Cascorbi, I.; Roots, I.; Brinkmann, U.; Zanger, U. M.; Eichelbaum, M. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003, 124 (1), 26-33.
73. Ho, G. T.; Soranzo, N.; Nimmo, E. R.; Tenesa, A.; Goldstein, D. B.; Satsangi, J. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum. Mol. Genet. 2006, 15 (5), 797-805.
74. Brant, S. R.; Panhuysen, C. I.; Nicolae, D.; Reddy, D. M.; Bonen, D. K.; Karaliukas, R.; Zhang, L.; Swanson, E.; Datta, L. W.; Moran, T.; Ravenhill, G.; Duerr, R. H.; Achkar, J. P.; Karban, A. S.; Cho, J. H. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet. 2003, 73 (6), 1282-92.
75. Panwala, C. M.; Jones, J. C.; Viney, J. L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdrla, spontaneously develop colitis. J. Immunol. 1998, 161 (10), 5733-44.
76. Fischer, S.; Lakatos, P. L.; Lakatos, L.; Kovacs, A.; Molnar, T.; Altorjay, I.; Papp, M.; Szilvasi, A.; Tulassay, Z.; Osztovits, J.; Papp, J.; Demeter, P.; Schwab, R.; Tordai, A.; Andrikovics, H. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scand. J. Gastroenterol. 2007, 42 (6), 726-33.
77. Oostenbrug, L. E.; Dijkstra, G.; Nolte, I. M.; van Dullemen, H. M.; Oosterom, E.; Faber, K. N.; de Jong, D. J.; van der Linde, K.; te Meerman, G. J.; van der Steege, G.; Kleibeuker, J. H.; Jansen, P. L. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease. Scand. J. Gastroenterol. 2006, 41 (10), 1174-82.
78. Langmann, T.; Moehle, C.; Mauerer, R.; Scharl, M.; Liebisch, G.; Zahn, A.; Stremmel, W.; Schmitz, G. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004, 127 (1), 26-40.
79. Dring, M. M.; Goulding, C. A.; Trimble, V. I.; Keegan, D.; Ryan, A. W.; Brophy, K. M.; Smyth, C. M.; Keeling, P. W.; O'Donoghue, D.; O'Sullivan, M.; O'Morain, C.; Mahmud, N.; Wikstrom, A. C.; Kelleher, D.; McManus, R. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2006, 130 (2), 341-8, quiz 592.
80. Bachs, L.; Pares, A.; Elena, M.; Piera, C.; Rodes, J. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet 1989, 1 (8638), 574-6.
81. Fiorucci, S.; Clerici, C.; Antonelli, E.; Orlandi, S.; Goodwin, B.; Sadeghpour, B. M.; Sabatino, G.; Russo, G.; Castellani, D.; Willson, T. M.; Pruzanski, M.; Pellicciari, R.; Morelli, A. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. J. Pharmacol. Exp. Ther. 2005, 313 (2), 604-12.
82. Liu, Y.; Binz, J.; Numerick, M. J.; Dennis, S.; Luo, G.; Desai, B.; MacKenzie, K. I.; Mansfield, T. A.; Kliewer, S. A.; Goodwin, B.; Jones, S. A. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J. Clin. Invest. 2003, 112 (11), 1678-87.
83. Xie, W.; Radominska-Pandya, A.; Shi, Y.; Simon, C. M.; Nelson, M. C.; Ong, E. S.; Waxman, D. J.; Evans, R. M. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (6), 3375-80.
84. Staudinger, J. L.; Goodwin, B.; Jones, S. A.; Hawkins-Brown, D.; MacKenzie, K. I.; LaTour, A.; Liu, Y.; Klaassen, C. D.; Brown, K. K.; Reinhard, J.; Willson, T. M.; Koller, B. H.; Kliewer, S. A. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (6), 3369-74.
85. Marschall, H. U.; Wagner, M.; Zollner, G.; Fickert, P.; Diczfalusy, U.; Gumhold, J.; Silben, D.; Fuchsbichler, A.; Benthin, L.; Grundstrom, R.; Gustafsson, U.; Sahlin, S.; Einarsson, C.; Trauner, M. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005, 129 (2), 476-85.
86. Guo, G. L.; Lambert, G.; Negishi, M.; Ward, J. M.; Brewer, H. B. Jr.; Kliewer, S.A.; Gonzalez, F.J.; Sinai, C.J. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 2003, 278 (46), 45062-71.
87. Slaviero, K. A.; Clarke, S. J.; Rivory, L. P. Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. 2003, 4 (4), 224-32.
88. Mani, S.; Huang, H.; Sundarababu, S.; Liu, W.; Kalpana, G.; Smith, A. B.; Horwitz, S. B. Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents. Clin. Cancer Res. 2005, 11 (17), 6359-69.
89. Masuyama, H.; Suwaki, N.; Tateishi, Y.; Nakatsukasa, H.; Segawa, T.; Hiramatsu, Y. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol. Endocrinol. 2005, 19 (5), 1170-80.
90. Jang, S. H.; Wientjes, M. G.; Au, J. L. Kinetics of P-glycoprotein- mediated efflux of paclitaxel. J. Pharmacol. Exp. Ther. 2001, 298 (3), 1236-42.
91. Takami, N.; Sakamoto, H.; Yamamoto, T. Steroid and xenobiotic receptor (SXR) is a key system for the acquisition of cisplatin resistance in endometrial cancer cells. J. Int. Med. Res. 2003, 31 (2), 59-68.
92. Yamaguchi, H.; Hishinuma, T.; Endo, N.; Tsukamoto, H.; Kishikawa, Y.; Sato, M.; Murai, Y.; Hiratsuka, M.; Ito, K.; Okamura, C.; Yaegashi, N.; Suzuki, N.; Tomioka, Y.; Goto, J. Genetic variation in ABCB1 influences paclitaxel pharmacokinetics in Japanese patients with ovarian cancer. Int. J. Gynecol. Cancer 2006, 16 (3), 979-85.
93. Bachs, L.; Pares, A.; Elena, M.; Piera, C.; Rodes, J. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 1992, 102 (6), 2077-80.
94. Hartmann, G.; Kim, H.; Piquette-Miller, M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int. Immunopharmacol. 2001, 1 (2), 189-99.
95. Piquette-Miller, M.; Pak, A.; Kim, H.; Anari, R.; Shahzamani, A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm. Res. 1998, 15 (5), 706-11.
96. Kalitsky-Szirtes, J.; Shayeganpour, A.; Brocks, D. R.; Piquette-Miller, M. Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats. Drug Metab. Dispos. 2004, 32 (1), 20-7.
97. Wang, J. H.; Scollard, D. A.; Teng, S.; Reilly, R. M.; Piquette-Miller, M. Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging. J. Nucl. Med. 2005, 46 (9), 1537-45.
98. Hartmann, G.; Cheung, A. K.; Piquette-Miller, M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther. 2002, 303 (1), 273-81.
99. Tang, W.; Yi, C.; Kalitsky, J.; Piquette-Miller, M. Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. Mol. Cell Biol. Res. Commun. 2000, 4 (2), 90-7.
100. Cherrington, N. J.; Slitt, A. L.; Li, N.; Klaassen, C. D. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab. Dispos. 2004, 32 (7), 734- 41.
101. Li, N.; Choudhuri, S.; Cherrington, N. J.; Klaassen, C. D. Down-regulation of mouse organic anion-transporting polypeptide 4 (Oatp4; Oatp1b2; Slc21a10) mRNA by lipopolysaccharide through the toll-like receptor 4 (TLR4). Drug Metab. Dispos. 2004, 32 (11), 1265-71.
102. Siewert, E.; Dietrich, C. G.; Lammen, F.; Heinrich, P. C.; Matern, S.; Gartung, C.; Geier, A. Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem. Biophys. Res. Commun. 2004, 322 (1), 232-8.
103. Green, R. M.; Beier, D.; Gollan, J. L. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 1996, 111 (1), 193-8.